In T cell-dependent autoimmune diseases, studies have found that deletion of Bcl-3 in T cells blocks colitis and experimental autoimmune encephalomyelitis caused by T cell metastasis (89). Here, BCL3 is linked to experimental autoimmune encephalomyelitis.